Pharmatest to exhibit and present at the AACR 2023 Annual Meeting
We will be presenting three abstracts at the American Association for Cancer Research (AACR) Annual Meeting 2023 held in Orlando April
06/04/2023
Current news
Exciting results in new study on bone-metastatic castration-resistant prostate cancer
Proud to present the results of our latest collaboration with Bayer AG and Aurexel Life Sciences! Our newest article, published
09/02/2023
October – breast cancer awareness month
Breast cancer is the most common cancer globally, according to the World Health Organization. It accounts for 12% of all
25/10/2022
Pharmatest to present at ASBMR 2022 Annual Meeting
The American Society for Bone and Mineral Research (ASBMR) is a professional, scientific, and medical society with approximately 4,000 members
07/09/2022
Pharmatest announces its attendance at the AACR 2022. Visit our booth #1465!
Pharmatest is excited to join the meeting onsite from April 8 through 13, 2022 at the Ernest N. Morial Convention
25/03/2022
Holiday Greetings
As 2021 is coming to an end, we would like to thank all of our customers, partners and employees for
21/12/2021
Breast Cancer Awareness Month
Early detection saves lives October is Breast Cancer Awareness month. It is an important cause to raise awareness and understanding
20/10/2021
Proud to announce ISO 9001:2015 certification
We are delighted to announce that Pharmatest is now an ISO 9001:2015 certified company. This is an internationally recognized standard
14/06/2021
Promising therapy for multiple myeloma bone disease has been published
Myeloma bone disease is still incurable and is characterized by destructive osteolytic lesions causing bone pain, fractures, and hypercalcemia. Our
04/06/2021
Pharmatest receives the French Tax Credit Incentive (Crédit d’Impôt Recherche CIR)
Pharmatest has received the renewal of its French Tax Credit approval for the years 2021, 2022, 2023. The French Tax
26/05/2021
Attending the largest annual cancer research meeting AACR
Along with 11,000 other participants, Pharmatest will be taking part of the virtual AACR 2021 Meeting starting on April 10.
09/04/2021
LIVE Webinar: To Overcome the Challenges in Cancer Treatment – From Bone Metastasis to Nanotechnology
Pharmatest would like to invite you to the live Webinar on Tuesday 4th May at 4 pm BST (6 pm
08/04/2021
NEW LEAD MOLECULE FOR NOVEL ANTI-OSTEOPOROTIC DRUG PUBLISHED
A new lead molecule (compound E197) for novel anti-osteoporotic drug has been identified at the Montpellier Cell Biology Research Center
10/12/2020
PHARMATEST TO ATTEND 3RD ANNUAL ADVANCES IN IMMUNO-ONCOLOGY US CONGRESS
This week on Thursday October 15th our oncology experts will virtually travel and attend the 3rd Annual Advances in Immuno-Oncology
14/10/2020
ASBMR 2020 VIRTUAL ANNUAL MEETING
Pharmatest will be taking part of the virtual ASBMR 2020 Meeting starting on Friday, September 11. We are excited about this year’s
10/09/2020
PHARMATEST AT AACR 2020 VIRTUAL MEETING
PHARMATEST AT AACR 2020 VIRTUAL MEETINGPharmatest is very excited to participate in AACR virtual meeting II on June 22-24. Registration
16/06/2020
SUPPORTING THE RESEARCH RELATED TO COVID-19
In severe cases of SARS-CoV-2 infections, the immune system has been hyper-activated, triggering a cytokine release storm (CRS). CRS is
30/04/2020
PHARMATEST’S PROJECTS AND SAFETY DURING THE COVID-19 OUTBREAK
Pharmatest’s projects and safety during the COVID-19 outbreak To ensure the health and safety of Pharmatest’s employees, we have adopted
20/03/2020
